Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Drops By 19.7%

PureTech Health plc (OTCMKTS:PTCHF) was the recipient of a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 15,100 shares, a drop of 19.7% from the November 30th total of 18,800 shares. Based on an average daily trading volume, of 5,800 shares, the short-interest ratio is currently 2.6 days.

PureTech Health Stock Performance

Shares of PureTech Health stock remained flat at $2.00 during trading on Monday. PureTech Health has a 52-week low of $1.81 and a 52-week high of $3.00. The company’s 50-day moving average is $2.06 and its 200-day moving average is $2.11.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.